LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $242,000 | +0.4% | 2,428 | +15.0% | 0.44% | +22.4% |
| Q2 2019 | $241,000 | +10.0% | 2,111 | +21.0% | 0.36% | +20.2% |
| Q1 2019 | $219,000 | +5.8% | 1,745 | +14.9% | 0.30% | +59.7% |
| Q3 2017 | $207,000 | -19.5% | 1,519 | -28.1% | 0.19% | -20.9% |
| Q2 2017 | $257,000 | -34.8% | 2,113 | -43.2% | 0.24% | -19.5% |
| Q1 2017 | $394,000 | +49.8% | 3,719 | +43.6% | 0.29% | +39.0% |
| Q4 2016 | $263,000 | – | 2,589 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |